[Vulvar lichen sclerosus]

Contracept Fertil Sex. 1993 Mar;21(3):237-40.
[Article in French]

Abstract

Lichen sclerosus's pathogeny, the most frequent vulvar dystrophy predominant at the start of menopause, is still enigmatic. Its repercussions on the functional level can be disabling. Its clinical sides include atrophy and sclerosis. The evolution of the past towards great atrophies (kraurosis vulvae) may today be prevented by early diagnosis and treatment (essentially dermocorticoïde). Even if the risk of degenerescence is low, it's not negligible and these patients must be put under steady surveillance.

Publication types

  • English Abstract
  • Review

MeSH terms

  • Adrenal Cortex Hormones / therapeutic use
  • Age Factors
  • Diagnosis, Differential
  • Female
  • Humans
  • Lichen Sclerosus et Atrophicus* / classification
  • Lichen Sclerosus et Atrophicus* / diagnosis
  • Lichen Sclerosus et Atrophicus* / epidemiology
  • Lichen Sclerosus et Atrophicus* / etiology
  • Lichen Sclerosus et Atrophicus* / therapy
  • Menopause
  • Middle Aged
  • Risk Factors
  • Vulvar Lichen Sclerosus* / classification
  • Vulvar Lichen Sclerosus* / diagnosis
  • Vulvar Lichen Sclerosus* / epidemiology
  • Vulvar Lichen Sclerosus* / etiology
  • Vulvar Lichen Sclerosus* / therapy

Substances

  • Adrenal Cortex Hormones